Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700010028

Trial Profile

Clinical Trials Insight: 700010028

Phase of Trial: Phase III

Latest Information Update: 22 Jul 2008

At a glance

  • Drugs Mifamurtide (Primary) ; Cisplatin; Doxorubicin; Ifosfamide; Methotrexate
  • Indications Osteosarcoma
  • Focus Registrational; Therapeutic Use
  • Sponsors IDM Pharma
  • Most Recent Events

    • 22 Jul 2008 Results for 91 patients with metastatic disease reported at ASCO 2008.
    • 01 Jul 2008 CHMP has requested additional data analyses on the phase III L-MTP-PE trial before it will offer an opinion on the MAA application. IDM expect an opinion in the third quater of 2008.
    • 02 Jun 2008 Results of a subgroup analysis presented at the Annual Meeting of the American Society of Clinical Oncology 2008 and an IDM Pharma media release (9089573).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top